Smith & Nephew: Work To Be Done But Still Long-Term Potential
The Good Brigade/DigitalVision via Getty Images Fourth Quarter Results1,2 Revenue Full Year Results1,2 Revenue Operating profit Operating profit margin (%) EPS (cents) Trading profit Trading profit margin (%) EPSA (cents) Medical devices and supplies manufacturer Smith & Nephew (NYSE:SNN) (OTCPK :SNNUF) has had an underwhelming several years, but at its core is a well- positioned business in a business area with premium pricing and long-term growth prospects. My last piece on the name was September 2022's S ...